scout
Opinion|Videos|December 13, 2024

Role of Step-Up Dosing

Panelists discuss how this patient was admitted after the day 1 dose of talquetamab for observation for CRS and ICANS. Patients such as this are given a 0.01-mg/kg dose on the first day, a 0.06-mg/kg dose on day 3, and a 0.04-mg/kg dose on day 5 if there are no issues. The patient is then monitored for 48 hours and is discharged before getting the 0.08-mg/kg dose.

Episodes in this series

Video content above is prompted by the following:

  • Can you describe the dosing regimen for talquetamab, both as an inpatient and outpatient?
  • Please highlight why we decreased dosing frequency and what the data are telling us to do now?
  • Given the toxicity associated with talquetamab, can you describe the conversations with the patients when giving the first dose of talquetamab?

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!

Related Content